Topics

Experimental medication to prevent heart disease may treat chemo-resistant ovarian cancer

20:00 EDT 25 Mar 2020 | AAAS

(University of Colorado Anschutz Medical Campus) Study shows CPT1A may help ovarian cancer cells spread, also resist chemo. Group moves toward clinical trial of CPT1A inhibitor, etomoxir, in chemo-resistant ovarian cancer.

Original Article: Experimental medication to prevent heart disease may treat chemo-resistant ovarian cancer

NEXT ARTICLE

More From BioPortfolio on "Experimental medication to prevent heart disease may treat chemo-resistant ovarian cancer"

Quick Search

Relevant Topics

Ovarian Cancer
Ovarian Cancer is cancer that starts in the female reproductive organs, the ovaries. It is the fifth most common cancer among women.  Women at risk of Ovarian Cancer are those who have had few children (or had children at an older age), carriers o...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...